## Abstract In this editorial we have summarised ten years of evidence relating to the use of cholinesterase inhibitors in Alzheimer's and other dementias. We have presented this evidence in the context of the evolution of public and professional awareness of dementia and its management and prescri
Synthesis of carbamoylpiperidine-type cholinesterase inhibitors
β Scribed by Ronald P. Quintana; Terry D. Smith; Linda F. Lorenzen
- Publisher
- John Wiley and Sons
- Year
- 1965
- Tongue
- English
- Weight
- 329 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Nerve agents, highly toxic organophosphorus cholinesterase inhibitors, inhibit acetylcholinesterase and cause an accumulation of acetylcholine. Clinical effects depend on the route and amount of exposure and include miosis, bronchoconstriction, excessive secretions, vomiting, seizures, and cessation
fact may be ascribed to a primarily biological origin of the disease, not correlated with other possible causative events (e.g. chronic somatic diseases). On the other hand, in patients with reactive depressive symptoms a higher prevalence of somatic dysfunction (e.g. number of diseases, Charlson In
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v